Valium (diazepam) is still prescribed, but its role in modern medicine has narrowed dramatically since the 1970s, when it was the single most prescribed drug in the United States. Doctors today reach for it in specific clinical situations where its pharmacological profile still makes sense, while avoiding the broad, open-ended prescribing that once made it a cultural icon. The story of Valium’s decline is really about the medical profession learning hard lessons about tolerance, dependence, and drug interactions over several decades.
Where Diazepam Still Holds Its Ground
Diazepam has FDA approval for treating anxiety disorders, acute alcohol withdrawal, skeletal muscle spasms, and convulsive disorders such as status epilepticus. It is also commonly used off-label for conditions including insomnia, restless legs syndrome, and sedation before or after surgery. It comes in oral tablets, an oral solution, intravenous and intramuscular preparations, and since 2020, a nasal spray with a one-way applicator for emergencies.1PubMed Central. Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability That range of formulations keeps diazepam relevant in settings where other benzodiazepines cannot be delivered as easily.
The areas where diazepam remains genuinely useful tend to be acute, short-duration situations rather than ongoing daily use. Alcohol withdrawal is perhaps the clearest example. Benzodiazepines as a class are considered the gold standard for managing alcohol withdrawal, backed by more evidence than any competing drug class.2PubMed Central. Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond A systematic review confirmed that benzodiazepines have the strongest evidence base for this purpose, with anticonvulsants a distant second.3PubMed Central. Clinical management of alcohol withdrawal: A systematic review Diazepam’s long half-life is actually an advantage here because it provides a smoother tapering effect as it clears the body, reducing the risk of rebound withdrawal symptoms. In emergency departments, both diazepam and lorazepam perform similarly for alcohol withdrawal agitated delirium, with no meaningful difference in symptom improvement at 24 hours.4The American Journal of Emergency Medicine. Front-loaded diazepam versus lorazepam for treatment of alcohol withdrawal agitated delirium
Seizure Emergencies
Status epilepticus, a life-threatening condition where seizures do not stop on their own, is another area where diazepam remains a frontline drug. A landmark trial of out-of-hospital treatment by paramedics found that diazepam terminated status epilepticus by the time patients reached the emergency department in about 43% of cases, compared with roughly 21% for placebo. Lorazepam performed somewhat better at about 59%, and both benzodiazepines had similar rates of respiratory or circulatory complications, around 10%.5PubMed. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus That study helped establish lorazepam as the preferred first choice in many adult emergency protocols, but diazepam did not disappear. A later randomized trial in children found virtually identical outcomes: seizure cessation within 10 minutes without recurrence within 30 minutes occurred in about 72% of the diazepam group and about 73% of the lorazepam group.6JAMA. Lorazepam vs Diazepam for Pediatric Status Epilepticus: A Randomized Clinical Trial
Diazepam’s availability as a rectal gel (sold as Diastat) carved out a particular niche in pediatric neurology. Parents of children with epilepsy or complex febrile seizures can administer it at home when seizures are prolonged or come in clusters. In one study of repeated home use, about 77% of administrations resulted in no further seizures for the next 12 hours.7PubMed. An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance A prospective study found that when parents used rectal diazepam gel, seizures stopped without needing an emergency department visit about 84% of the time, and parental stress decreased over the follow-up period.8Pediatric Neurology. Utility of Rectal Diazepam Gel in Pediatric Seizure Clusters and Prolonged Seizures This is a case where diazepam’s specific formulation, not just the drug itself, makes it hard to replace.
Muscle Spasticity
The FDA has approved only four drugs specifically as antispasticity agents: baclofen, diazepam, dantrolene, and tizanidine. For spasticity caused by spinal cord injury or multiple sclerosis, centrally acting drugs like baclofen, tizanidine, and diazepam are generally preferred.9Muscle & Nerve. Traditional pharmacological treatments for spasticity part II: General and regional treatments In practice, diazepam tends to be a second or third choice here. A crossover trial comparing baclofen and diazepam found both drugs improved spasticity to a similar degree, but diazepam caused more side effects, particularly excessive daytime drowsiness.10PubMed. Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy That sedation problem runs through nearly every use of diazepam and is one of the main reasons it has lost ground to alternatives in multiple clinical areas.
Why Prescribing Dropped
The decline of Valium was not caused by a single discovery but by an accumulation of concerns that piled up over the 1980s and 1990s. The biggest was dependence. Research showed that tolerance to benzodiazepines develops with remarkable speed: functional tolerance is evident even after just two doses, and physical dependence can be detected within 24 hours of starting treatment. After about seven days of continuous use, dependence approaches its maximum.11Neuroscience & Biobehavioral Reviews. Time course for development of benzodiazepine tolerance and physical dependence This was a revelation at a time when millions of people were taking Valium daily for months or years. Research into specific receptor subtypes has since shown that receptors containing the alpha-1 subunit play a key role in both the addictive and tolerance-building properties of benzodiazepines.12PubMed Central. Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
The other major force was the rise of SSRIs and other antidepressants as treatments for anxiety disorders. Starting in the late 1980s, prescribing patterns for anxiety shifted progressively from benzodiazepines toward newer antidepressants. A systematic review and meta-analysis that examined whether controlled comparisons actually supported this shift noted that both drug classes are effective for anxiety disorders in placebo-controlled trials, yet the shift happened anyway.13Psychotherapy and Psychosomatics. Efficacy and Tolerability of Benzodiazepines versus Antidepressants in Anxiety Disorders: A Systematic Review and Meta-Analysis The preference for antidepressants was driven less by superior efficacy and more by their lack of physical dependence, which made them safer for the long-term use that anxiety disorders often require. That is the real irony of Valium’s decline in anxiety treatment: it was not that the drug stopped working, but that prescribing it for months at a time created problems that outweighed the benefits for most patients.
The Opioid Crisis Made Things Worse
Benzodiazepines had already been falling out of broad favor when the opioid crisis created a new reason to restrict them. The combination of an opioid and a benzodiazepine dramatically increases the risk of fatal respiratory depression, because both drug classes suppress the brain’s drive to breathe. Opioids and benzodiazepines were frequently co-prescribed to patients with pain and psychiatric or neurological conditions, and co-prescribing raised the risk of severe respiratory depression and death. The FDA responded by adding boxed warnings, the most serious kind, to the labels of all opioids and all benzodiazepines describing this risk.14Toxicology Reports. Developing an animal model to detect drug–drug interactions impacting drug-induced respiratory depression That regulatory action, issued in 2016, made prescribers think twice about writing benzodiazepine prescriptions for anyone already on opioid therapy, which was a large number of patients.
State-level policy added another layer. Prescription drug monitoring programs, which require prescribers to check a database before writing certain prescriptions, reduced dispensing volumes for both opioids and benzodiazepines. After one such mandatory review law took effect, benzodiazepine dispensing fell by about 1.68 million doses per month in that state alone.15Drug and Alcohol Dependence. Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing These monitoring systems did not single out diazepam, but they applied friction to the entire class and made casual or reflexive prescribing less common.
Risks for Older Adults
One population where diazepam is particularly problematic is older adults. Diazepam’s long half-life, which can stretch well beyond 24 hours and is even longer in older bodies that metabolize drugs more slowly, means the drug accumulates over days. This increases the risk of sedation, confusion, and impaired balance. Evidence suggests that benzodiazepines with long half-lives contribute to falls, which are already a major health concern in older age.16PubMed. Problems and pitfalls in the use of benzodiazepines in the elderly A clinical review found that benzodiazepines contribute to fall risk through multiple mechanisms including dizziness, impaired balance, sedation, muscle weakness, and drops in blood pressure upon standing.17PubMed Central. Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review
The Beers Criteria, a widely used list of medications that are potentially inappropriate for older adults, includes long-acting benzodiazepines like diazepam. This does not mean diazepam is never prescribed to someone over 65, but it does mean that a prescriber choosing it over a shorter-acting alternative needs a specific clinical reason. In practice, when older adults do receive a benzodiazepine, it tends to be a shorter-acting one like lorazepam or oxazepam. The shift away from diazepam in geriatric medicine was one of the earlier chapters in its broader decline.
Global Prescribing Patterns Tell a Different Story
While diazepam has been overtaken by newer drugs in much of Western medicine, its prescribing picture looks quite different depending on where you are. A study of community-dwelling older adults across seven European countries found that diazepam was the single most commonly prescribed benzodiazepine, accounting for about 28% of all benzodiazepine users, ahead of alprazolam at roughly 24% and bromazepam at about 23%. Benzodiazepine use itself varied enormously, from over 35% of older adults in Croatia and roughly 34% in Spain to far lower rates in countries like Turkey.18PubMed Central. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries
Among nursing home residents in Europe and Israel, the picture shifted somewhat. Overall benzodiazepine use ranged from about 14% in Germany to 44% in Israel, and the most frequently prescribed individual drugs were zopiclone, lorazepam, and oxazepam. Diazepam appeared in most countries but did not dominate the way it did in community settings.19PubMed Central. The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER study The difference likely reflects the geriatric safety concerns discussed above: in institutional settings where fall risk is closely monitored, clinicians lean toward shorter-acting options.
Dental prescribing offers another window into cross-country variation. In the U.S., England, and Australia, diazepam was the most commonly prescribed benzodiazepine by dentists, but American dentists prescribed benzodiazepines at vastly higher rates. By 2018, U.S. dental benzodiazepine prescribing ran about 28 times higher than English rates and 6 times higher than Australian rates per population.20American Journal of Preventive Medicine. Comparison of Dental Benzodiazepine Prescriptions From the U.S., England, and Australia From 2013 to 2018 These gaps hint that cultural attitudes toward sedation, patient expectations, and regulatory environments matter as much as the pharmacology itself.
Veterinary Medicine
An area where diazepam has barely lost any ground at all is veterinary practice. For dogs and cats experiencing status epilepticus, benzodiazepines remain the most common class of drugs used as initial treatment.21PubMed. Status epilepticus in dogs and cats, part 2: treatment, monitoring, and prognosis The concerns about long-term dependence that reshaped human prescribing are largely irrelevant in veterinary emergencies, where diazepam is given as a single dose or short course to stop an active seizure. Veterinary clinics stock it routinely, and many owners of epileptic dogs keep it at home for rescue use, much like the pediatric rectal gel discussed earlier. In this context, diazepam’s rapid onset and established safety profile keep it firmly in the toolkit.
The Cultural Dimension
Valium carries cultural baggage that newer drugs simply do not. By the mid-1960s, diazepam had become so widely prescribed, particularly to women for anxiety and stress, that The Rolling Stones memorialized it as “Mother’s Little Helper” in 1966. That song cemented a gendered cultural meaning around the drug that persists decades later.22PubMed Central. Mother’s little helper? Contrasting accounts of benzodiazepine and methadone use among drug-dependent parents in the UK Qualitative research among drug-dependent parents in the UK found something interesting: while opioid dependence was framed as stigmatizing, benzodiazepine use and dependence tended to be described in normalized, even positive terms. The cultural familiarity of Valium seemed to make people less likely to recognize it as a drug of dependence, even when they were dependent on it.
That normalization is both a legacy of Valium’s heyday and a continuing public health concern. The name “Valium” is so well known that it functions almost as a generic term for tranquilizers in popular culture, which can make people underestimate the drug’s risks. Doctors have had to navigate this perception gap for decades: a patient who would never accept a prescription labeled “benzodiazepine” might actively request “something like Valium” without recognizing they are the same thing.
What Modern Prescribing Looks Like in Practice
If you receive a diazepam prescription today, it will almost certainly look different from what a patient in 1975 would have been given. Contemporary guidelines emphasize the lowest effective dose for the shortest possible duration. For anxiety, that typically means days to a few weeks rather than months. For alcohol withdrawal, it means a tapering protocol over several days in a clinical setting. For seizure rescue, it means a single administration during an acute episode. The days of open-ended Valium prescriptions refilled month after month are, for the most part, over in countries with active prescribing oversight.
That said, some patients do remain on long-term benzodiazepine therapy, including diazepam. Patients who have taken the drug for years and are stable may continue it because the risks of abrupt discontinuation, including rebound anxiety, insomnia, and potentially dangerous withdrawal seizures, can outweigh the risks of continued low-dose use. Tapering someone off a benzodiazepine they have taken for a decade is a slow, careful process that not every patient can or wants to undertake. Diazepam’s long half-life actually makes it useful in this context as well: clinicians sometimes switch patients from a shorter-acting benzodiazepine to diazepam specifically to make the tapering smoother.
So the answer to whether Valium is still prescribed is a qualified yes. It remains in clinical use, it still appears in emergency departments and neurology clinics and veterinary hospitals around the world, and it is still the most commonly prescribed benzodiazepine in several countries. But the era of Valium as a default answer for stress, sleep trouble, or vague unease is firmly in the past. What remains is a drug used carefully, for defined indications, by prescribers who are far more aware of its downsides than their predecessors were.